Celogics highlights its iPSC derived Cardiomyocytes at 2022 SOT Annual Meeting and Tox Expo
Celogics showcased their unique high-quality cells during the SOT Annual Meeting and ToxExpo in San Diego, California from March 27-31, 2022
top of page
Newsroom
- Mar 7, 2022
Celogics hiring Technical Sales Manager in Washington
https://www.linkedin.com/jobs/view/2929516541 About the job Celogics develops high-quality human induced pluripotent stem cell products...
- Mar 7, 2022
Curi Bio and NEXEL Announce Celogics, Joint Venture to Develop Leading iPSC-derived Cell Products
Celogics, based in Seattle, will offer high-quality iPSC-derived cell products for drug discovery and safety testing October 26, 2021...
bottom of page